← All Anbio Biotechnology filings

Anbio Biotechnology F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
NNNN
Anbio Biotechnology
F-1/A: Anbio Biotechnology Refiles F-1 Registration Statement Amendment for IPO
Anbio Biotechnology refiles an amendment to its F-1 registration statement, primarily to re-file an exhibit, as it prepares for a potential IPO.
NASDAQ
NNNN
Anbio Biotechnology
F-1/A: Anbio Biotechnology Seeks Waiver for IPO Financial Reporting Requirement
Anbio Biotechnology requests a waiver from the SEC regarding the 12-month financial statement requirement for its initial public offering, citing impracticability and undue hardship.
NASDAQ
NNNN
Anbio Biotechnology
F-1/A: Anbio Biotechnology Files for IPO: Supply Agreement and Financial Details Revealed
Anbio Biotechnology's F-1/A filing details a supply agreement and key financial information as the company prepares for its initial public offering.
NASDAQ
NNNN
Anbio Biotechnology
F-1: Anbio Biotechnology Files for $8 Million Nasdaq IPO
Anbio Biotechnology, a Cayman Islands-based medical technology company, is seeking to raise $8 million through an initial public offering on the Nasdaq Global Market.